Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1999 of 6351
-
Can a ginkgo pill soothe both chest pain and depression?
Disease control CompletedTo evaluate the clinical efficacy of Ginkgo biloba dropping pills on improving the frequency of angina pectoris and the life quality of patients with stable angina pectoris and depression symptoms on the basis of the best western medicine treatment; Study on the clinical pharmaco…
Phase 4 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can fewer, stronger radiation doses before sarcoma surgery reduce wound problems?
Disease control OngoingThis phase II trial investigates the effects of hypofractionated radiation therapy before surgery on wound complications associated with surgery in treating patients with soft tissue sarcoma of the extremity (arms, hands, legs or feet) and superficial trunk that has not spread to…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug may help MDS patients need fewer blood transfusions
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of luspatercept (ACE-536) for the treatment of anemia due to Revised International Prognostic Scoring System (IPSS-R) very low, low, or intermediate risk myelodysplastic syndromes (MDS) in Chinese and Japanese parti…
Phase 2 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New injection schedule may boost vision in diabetic eye disease
Disease control OngoingNowadays, steroids and anti-VEGF are the first line treatment for diabetic macular edema. Ozurdex is the most frequently used steroid and has label for both first and second line treatment. Ozurdex treatment paradigm for patients with diabetic macular edema is to inject patient o…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Nerve zap device shows promise for bladder and bowel woes
Disease control CompletedTo assess the post-market clinical outcomes with use of the Axonics Sacral Neuromodulation System(s).
Sponsor: Axonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a phone app boost exercise and health in rural pregnancy?
Prevention CompletedThe goal of this pilot project is to test the feasibility and potential efficacy of the evidence-based mHealth app (BumptUp) for improving physical activity and subsequent health outcomes (i.e. obesity, hypertension, insulin resistance) among pregnant and postpartum women in a ru…
Sponsor: Western Kentucky University • Aim: Prevention
Last updated Aug 26, 2026 00:00 UTC
-
Could a hormone drug slow Alzheimer's? LUCINDA trial tests idea
Disease control OngoingThe LUCINDA Trial is a three-site, phase II, randomized, double-blind, placebo-controlled study of leuprolide acetate (Eligard) in women with Mild Cognitive Impairment or Alzheimer's Disease taking a stable dose of a cholinesterase inhibitor medication like donepezil. Its objecti…
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Magnetic pulses to the spine may help Parkinson's patients walk better
Symptom relief CompletedGait disorders are symptoms that significantly compromise the quality of life and functionality of patients with Parkinson's disease (PD). When they are not responsive to drug dopaminergic therapy and deep brain stimulation (DBS), the management of these symptoms is a challenge i…
Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Savings groups + health care = better HIV outcomes in rural kenya
Disease control CompletedThe objective of this project is to demonstrate the effectiveness and longer-term sustainability of a differentiated care delivery model for improving HIV treatment outcomes. The central hypothesis is that the integration of community-based HIV and NCD care with group microfinanc…
Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study aims to help head and neck cancer patients complete Life-Saving treatment
Disease control Recruiting nowPost-operative concomitant radiochemotherapy is a treatment that is difficult to achieve for several reasons. First of all, and by definition, these patients have had recent surgery, most often accompanied by several weeks of hospitalization and weight loss. In addition, the func…
Sponsor: Centre Henri Becquerel • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New targeted drug takes on stomach cancer in Head-to-Head trial
Disease control Completedthe primary objective of this study is to assess the efficacy (progression-free survival,PFS) of DCC-2618 (ripretinib, ZL-2307) and sunitinib in patients with advanced gastrointestinal stromal tumors after treatment with imatinib. This study will enroll approximately 98 subjects …
Phase 2 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New device aims to make brain aneurysm coiling safer
Disease control CompletedThe Comaneci Embolization Assist Device is indicated for use in the neurovasculature as a temporary endovascular device used to assist in the coil embolization of wide-necked intracranial aneurysms with a neck width ≤ 10 mm. A wide-necked intracranial aneurysm (IA) defines the ne…
Sponsor: Rapid Medical • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Immunotherapy plus chemo shows promise for rare bladder cancers
Disease control CompletedThis pilot study is evaluating how well pembrolizumab and combination chemotherapy before surgery work for the treatment of specific types of muscle-invasive bladder cancer that have unusual appearance (variants). Immunotherapy with monoclonal antibodies, such as pembrolizumab, m…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 26, 2026 17:36 UTC
-
Can tailored meals ease lung cancer treatment side effects?
Symptom relief OngoingThe NutriCare study aims to develop, implement, and evaluate the efficacy of an innovative intervention strategy (medically tailored meals plus nutrition counseling) to integrate nutrition into the standard of care for oncology to improve outcomes of vulnerable patients with lung…
Sponsor: Tufts University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
5-Day radiation blitz after mastectomy: game changer or risk?
Disease control OngoingThe purpose of this study is to see whether providing radiation on a shortened (compressed) schedule of 5 days in a row is a safe and effective approach to prevent cancer from coming back in people who have had a mastectomy.
Early phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Ancient herb Gou-Teng put to the test against early memory decline
Disease control CompletedMild cognitive impairment (MCI) is a pre-dementia condition commonly occurs in elderly people. As Hong Kong has become an aged society, the prevalence of dementia and MCI in Hong Kong has increased substantially in recent decades. To date, no effective pharmacological therapies a…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug duo aims to stall pancreatic cancer after chemo
Disease control OngoingThe main purpose of this research study is to determine the maximum tolerable dose (MTD) of SX-682 in combination with nivolumab in patients with metastatic pancreatic ductal adenocarcinoma who have completed at least 16 weeks of first line chemotherapy treatment without evidence…
Phase 1 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a common diabetes drug protect eyesight in stargardt disease?
Disease control OngoingBackground: ABCA4 retinopathy is a genetic disease in which the ABCA4 protein is absent or faulty. It can cause waste material to collect in the eye and may cause cells to die. The cell death can lead to vision loss. Researchers want to see if an oral drug called metformin can h…
Phase 1/2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Experimental nanoparticle boosts radiation against esophageal cancer
Disease control Recruiting nowThe purpose of this Phase I study is to determine the recommended phase 2 dose (RP2D) and safety profile of NBTXR3 activated by radiation therapy with concurrent chemotherapy for the treatment of patients with esophageal adenocarcinoma. NBTXR3 is a drug that when activated by rad…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
School-Based program aims to shield immigrant teens from trauma
Prevention CompletedThe present study is a randomized control trial to evaluate the efficacy and effectiveness of a school-based group prevention program (Fuerte) in San Francisco Unified School District Public Schools. In addition, the present study will also inform effective procedures for adaptat…
Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC